Solara Active, a company in the Pharmaceuticals industry, reported revenue of ₹417 crore and net profit of ₹28 crore for the September 2026 quarter.
Solara Active (NSE: SOLARA) closed at ₹628.25 on 20 Nov 2026, up 11.6% over the past year. Its market capitalisation is ₹3,049 crore and it trades at 64.4 times earnings.
Solara Active Pharma Sciences Ltd is engaged in business of manufacturing, production, processing, formulating, sale, import, export, merchandising, distributing, trading of APIs. It was formed through demerger of API business from Strides Shasun Ltd (currently named as Stride Pharma Sciences). Subsequently, it also acquired the human API business from Sequent Scientific Ltd during the same time, making it a pure play API company.
Descriptive research only, not investment advice. Evenstocks is not a SEBI-registered investment adviser.